Contact UsIntranet
Copy of Studio-988-Edit (1)

DR. CHEUNG, Allen Ka Loon (張嘉龍)

Assistant Professor

(+852) 3411 7745
(+852) 3411 7745
RRS 833

Education

Doctor of Philosophy (PhD), University of Sydney
Bachelor of Medical Science (Hons), University of Sydney

SELECTED PUBLICATIONS

  1. Chen M, Ma Y, Chen H, Dai J, Dong L, Yang C, Li Y, Luo H, Zhang R, Jin X, Yang L, Cheung AKL, Jia M, Song Z. HIV-1 genetic transmission networks among men who have sex with men in Kunming, China. PLoS One. 2018 Apr 26;13(4):e0196548. (IF=2.766)
  2. Cheung A.K., Kwok H., Huang Y., Chen M., Mo Y., Kong H., Lau T.C.K., Wu X., Lam K., Zhou J., Li J., Cheng L., Lee B.K., Peng Q., Lu X., An M., Hui W., Shan H., Zhou B., Wu H., Xu A., Yuen K.Y., Chen Z. Gut-homing Δ42PD1+Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV-1 infection. Nature Microbiology 2017 Oct;2(10):1389-1402. Epub 2017 Aug 14. (IF=14.174)
  3. Cheung A.K., Huang Y., Kwok H.Y., Chen M., Chen Z. Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells. Blood Advances 2017, 1(5):306-318. (IF=N/A)
  4. Wu X., Liu L., Cheung K., Wang H., Lu X., Cheung A.K., Liu W., Huang X., Li Y., Chen Z.W., Chen S.M.Y., Zhang T., Wu H., Chen Z. Brain invasion by CD4+ T cells infected with a transmitted/founder HIV-1BJZS7 during acute stage in humanized mice. J Neuroimmune Pharmacol 2016, 11(3):572-83. (IF=3.664)
  5. Cheng L., Tang X., Liu L., Peng J., Nishiura K, Cheung A.K., Guo J., Wu X., Hang Y.T., An M., Zhou J., Cheung K.W., Wang H., Guan X., Wu Z., Chen Z. Monoclonal antibodies specific to human Δ42PD1: a novel immunoregulator potentially involved in HIV-1 and tumor pathogenesis. mAbs 2015, 7(3):620-9. (IF=5.165)
  6. Tan Z., Zhou J., Cheung A.K., Yu Z., Cheung K.W., Liang J., Wang H., Lee, B.K., Man K., Liu L., Yuen, K.Y., Chen, Z. Vaccine-Elicited CD8+ T Cells Cure Mesothelioma by Overcoming Tumor-Induced Immunosuppressive Environment. Cancer Res. 2014, 74(21):6010-21. (IF=9.130)
  7. *Zhou J., *Cheung A.K.*Liu H. (*equal contribution), Tan Z., Tang X., Kang Y., Du Y., Wang H., Liu L., Chen Z. Potentiating functional antigen-specific CD8+ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine. Molecular Therapy. 2013, 21(7):1445-55. (IF=7.008)
  8. Zhou J., Cheung A.K., Tan Z., Wang H., Yu W., Du Y., Kang Y., Lu X., Li L., Yuen K.Y., Chen Z. PD1-based vaccine amplifies HIV-1 CD8+ T cells in mice. J Clin Invest. 2013, 123(6):2629-42. (IF=13.251)
  9. Kang Y., Wu Z., Lau T.C., Lu X., Liu L., Cheung A.K., Tan Z, Ng J, Liang J, Wang H, Li SK, Zheng B, Li B, Chen L, Chen Z. CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection and a resistant variant. J Biol Chem. 2012, 287(20):16499-509. (IF=4.010)
  10. Avdic S., Cao J.Z., Cheung A.K., Abendroth A., Slobedman B. Viral IL-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol 2011, 85:14:7465-7471. (IF=4.368)
  11. Slobedman B, Cao JZ, Avdic S, Webster B, McAllery S, Cheung AK, Tan JC, Abendroth A. Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol. 2010, 5(6):883-900. (IF=3.190)
  12. Cheung A.K., Gottlieb D.J., Plachter B., Pepperl-Klindworth S., Avdic S., Cunningham A.L., Abendroth A., Slobedman, B. The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 2009, 114:4128-4137. (IF=15.132)
  13. Slobedman S., Cheung A.K. Microarrays for the study of viral gene expression during human cytomegalovirus latent infection. In: Methods Mol Med 2008, 141:153-75.
  14. Cheung A.K., Abendroth A., Cunningham A.L., Slobedman B. Viral gene expression during the establishment of human cytomegalovirus latent infection of myeloid progenitor cells. Blood 2006, 108:3691-9. (IF=15.132)